Screening cancer epitopes, particularly neoepitope antigens, has become increasingly important in drug discovery and immunotherapy in recent years. Creative Biolabs provides various T and B cell-based epitope analysis assays, including T cell-based 3H-thymidine assay, to analyze cancer pathogenic epitopes.
Cancer antigen epitopes are specific molecules that target T and B cell receptors and induce complex immune responses. Cancer epitopes are typically derived from somatic mutations that cause tumorigenesis and may progress to various diseases and cancer. T cell proliferation analysis is a reliable and reproducible method to determine the presence and frequency of epitope-specific T cells. The use of a 3H-thymidine incorporation assay to investigate T cell proliferative response is a validated tool to screen and test cancer pathogenic epitopes.
Fig.1 Schematic representation of 3H-thymidine assay.1
While the 3H-thymidine assay has long been the gold standard, the field has evolved with the introduction of non-radioactive methods. The most notable alternative is the flow cytometry-based proliferation assay, which uses fluorescent dyes like carboxyfluorescein succinimidyl ester (CFSE) to track cell divisions.
Here is a brief comparison of the two methodologies:
| 3H-Thymidine Assay | Flow Cytometry Assay |
|---|---|
|
|
Contact us today to learn how our expertise can empower your immuno-oncology research.
Our workflow is designed for clarity and efficiency, ensuring a seamless experience from sample submission to final data delivery.
In the fast-moving field of immuno-oncology, accurately assessing T cell function is essential. At Creative Biolabs, we provide robust, reliable solutions for measuring T cell proliferation—a critical step in developing new immunotherapies, vaccines, and drug candidates. As a trusted partner in immunogenicity studies, we combine deep scientific expertise with advanced technology to support your research goals. Our T cell-based 3H-thymidine incorporation assay remains a gold standard for evaluating immunogenicity, offering direct, reproducible measurement of T cell proliferation to help advance your most promising therapeutic programs.
Discover how we can help your project succeed. Request a consultation today to begin the conversation about your specific goals.
A1: Our T cell-based 3H-thymidine assay directly measures DNA synthesis, providing a more direct and reliable measure of proliferation compared to colorimetric assays, which measure metabolic activity and can be influenced by other factors.
A2: While we specialize in the gold-standard 3H-thymidine assay for its precision, we can discuss your project requirements to determine if a non-radioactive method would be a suitable alternative.
A3: The 3H-thymidine assay is highly sensitive and can detect proliferation in low-frequency T cell populations, making it an excellent tool for epitope screening and rare T cell detection.
To further support your research, we recommend the following complementary services:
Creative Biolabs offers advanced ELISpot assays for cancer epitope analysis, leveraging its mature platform and expert team. This highly sensitive assay measures cytokine secretion activity to identify antigen-specific humoral and cellular immunity.
Learn More →Creative Biolabs offers the FluoroSpot assay, an advanced alternative to ELISpot. This highly sensitive assay uses fluorochrome-conjugated detection antibodies to detect secreted cytokines or antibodies, enabling functional analysis of up to seven subsets of immune cells.
Learn More →Creative Biolabs is dedicated to accelerating your therapeutic research. Our team of experts is ready to discuss your specific needs and provide a tailored solution. For detailed information and to discuss your project, please reach out to us.
Reference